Identification of genes involved in in vitro differentiation induction of embryonic stem cells (ESCs) into hematopoietic stem cells (HSCs) 
Introduction
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) can be differentiated into various type of cells in the body. 1 Establishment of human iPSCs has led to new clinical strategies using iPSCs as universal sources for regeneration therapy for damaged organs and tissues. 2 On the other hand, vigorous self-renewal of iPSCs could pose a risk for uncontrolled cell behavior in vivo, potentially resulting in teratoma formation. Therefore, lineage-directed in vitro differentiation of iPSCs into a desirable cell type is critical for their use in therapeutic applications.
Among the various methods for in vitro differentiation of ESCs/iPSCs, reliable protocols for hematopoietic cell differentiation have already been established, i.e., embryoid body formation, 3 culture on type-IV collagen-coated plates, 4 co-culture with OP9 stromal cells, 5, 6 and combinations of these approaches. 7 In mammals, hematopoiesis is supported by a small number of hematopoietic stem cells (HSCs) from which more than 8 distinct lineages of mature blood cells are continuously produced. During in vitro ESC differentiation to the hematopoietic lineage, Flk1 + mesodermal cells, including hemangioblasts, are differentiated from ESCs. 9 HPCs are then generated from these Flk1 + cells. Although primitive erythrocytes and HPCs are serially emerged, LTR-HSCs are not efficiently generated from ES cells without genetic manipulation, i.e. over-expression of Hoxb4. 10 To amplify the iPSCs-derived HPCs, we focused on the Lhx2 (LH2) gene, which encodes a LIMhomeobox transcription factor, since enforced expression of Lhx2 has been reported to facilitate ex vivo expansion of adult bone marrow HSCs and to immortalize ESC-derived HPCs. 11, 12 Studies of Lhx2-deficient mice have revealed that Lhx2 is involved in cell fate determination in a wide variety of organs and tissues. [13] [14] [15] In particular, Lhx2 is required for the development and preservation of hair follicle stem cells. 16 Here, we show that the enforced expression of Lhx2 conferred HSC-like ability to mouse ESC/iPSC-derived hematopoietic cells. These HSC-like cells could colonize bone marrow and continuously produce multi-lineage hematopoietic cells for more than 4 months when transplanted into lethally irradiated recipient mice. These findings suggest that Lhx2 might become a novel molecular tool to amplify HSCs/HPCs derived from ESCs/iPSCs.
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Methods

Cell culture
Two mouse ESC lines, C57BL/6-derived RENKA and 129/Ola-derived E14tg2a, were used in this study. RENKA ESCs and iPSCs were maintained on mitomycin C (Sigma, St. Louis, MO)-treated mouse embryonic fibroblasts (MMC-MEFs) in DMEM-based ES-medium which contained DMEM (Sigma) supplemented with 15% fetal calf serum (FCS; JRH biosciences, Lenexa, KS), 0.1 mM non-essential amino acids (Invitrogen, Carlsbad, CA), 1 mM sodium pyruvate (Invitrogen), 0.1 mM 2-mercaptoethanol (Sigma), 50 µg/mL penicillin, 75 µg/mL streptomycin, and ESGRO (Invitrogen). E14tg2a ESCs were cultured on 0.1% gelatin-coated plates in GMEM-based ESmedium in which GMEM (Sigma, St. Louis, MO) and leukemia inhibitory factor (LIF) were used instead of DMEM and ESGRO, respectively. LIF was prepared from the supernatant of CHO-LIF cells expressing exogenous LIF. OP9 stromal cells were maintained in OP9-medium containing α-MEM (Invitrogen) supplemented with 20% FCS, non-essential amino acids, penicillin and streptomycin.
The PLAT-E retrovirus packaging cell line was maintained in DMEM supplemented with 10% FCS, penicillin and streptomycin. All micro-photographic images were obtained using an Olympus Provis microscope with a UPlan APO 40x/0.85 numeric aperture objective lens, an Olympus DP70 camera, and DC controller software (all from Olympus, Tokyo, Japan) under ambient conditions. The images were processed using Adobe Photoshop (Adobe Systems, Mountain View, CA).
In vitro hematopoietic differentiation of mouse ESCs/iPSCs
In vitro differentiation of hematopoietic cells from ESCs/iPSCs was performed by co-culturing with OP9 stromal cells. 17 In some experiments, day 5 differentiated cells were used for retroviral transduction experiments. Thereafter, 1 -2 x 10 5 of day 5 differentiated cells were sub-cultured on OP9 cells in each wells of 6 well plates in the presence of appropriate cytokines. To expand the KSL cells, 10 ng/mL murine Interleukin-6 (IL-6, Peprotech, Rocky Hill, NJ) and 50 ng/mL murine stem cell factor (SCF, kindly provided by Kirin Brewery, Takasaki, Japan) were added to the culture. To induce erythroid cells, megakaryocytes and myeloid cells, 2 U/mL human erythropoietin (EPO, Kirin), 10 ng/mL human thrombopoietin (TPO, Kirin), 10 ng/mL human macrophage colony stimulating factor (M-CSF, Morinaga milk, Tokyo, Japan), 10 ng/mL murine granulocyte/macrophage colony stimulating factor (GM-CSF, Peprotech), or murine interleukin-3 (IL-3) were added, beginning on day 5 of differentiation. IL-3 was produced from the X63 melanoma cell line, a kind gift from Dr H. Karasuyama (Tokyo Medical and Dental University, Tokyo, Japan). Between day 8 and day 10 of the in vitro differentiation, floating and loosely attached cells were collected by vigorous pipetting and re-seeded onto OP9 cells. 
FACS analyses and colony assays
The in vitro differentiated hematopoietic cells were harvested by gentle pipetting. The cells were stained with various antibodies (Supplemental information). After the multi-color staining, the hematopoietic cells were analyzed by FACSCalibur or FACSAria (BD Bioscience). Optical filter sets were installed to detect EGFP and EYFP simultaneously (535AF LP mirror/520DRLP BP filter for EYFP and 510AF LP mirror/502LP BP filter for EGFP). The flowcytometric data were analyzed using FlowJo software (Treestar, San Carlos, CA).
The cells (10 4 ) were cultured in Methocult M3434 containing IL-6, IL-3, SCF and EPO (Stem Cell Technology, Vancouver, Canada) supplemented with TPO for 7 days. For the colony formation assays, Lhx2-transduced hematopoietic cells were sorted from the bone marrow of recipient mice 12 weeks after transplantation, and two thousand cells were used in each assay.
The cells were adhered to slides using Cytospin 4 (Thermo Shandon, Waltham, MA), followed by staining with Diff-Quick solution (Sysmex, Kobe, Japan). Images were analyzed using an inverted microscope (FSX-100, Olympus, Tokyo, Japan).
PCR and western blotting
Total RNA was recovered using a RNeasy mini kit (Qiagen, Valencia, CA) and examined by RT-PCR using the Thermoscript RT-PCR system (Invitrogen). In some experiments, cDNAs were serially diluted and amplified. Gapdh or β-actin were used as a template control. To analyze immunoglobulin rearrangement, 4 x 10 5 cells were lysed in buffer containing 60 µg/mL proteinase K (Nacalai Tesque, Kyoto, Japan), 0.1% Triton X-100, and 10 mM Tris-HCl (pH 8.0); incubated at 55˚C for 60 minutes; and denatured at 95˚C for 12 minutes. Genomic PCR was performed using rTaq polymerase (TOYOBO, Tokyo, Japan). The gene fragments for the immunoglobulin heavy chain (IgH) and light chain (IgL) were amplified using primers for VHγ3.8 and JH4 and Vλ1 and Jλ1,3, respectively.
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All of the primer sequences are listed in Table S1 . The amplified DNA were visualized by ethidium bromide staining. Westen blotting was carried out as previously described.
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Plasmids
The retroviral vector for Lhx2 was constructed by inserting mouse Lhx2 cDNA, a kind gift from Dr. 
Retroviral transduction
The retroviral vectors were transfected into PLAT-E cells using Lipofectamine 2000 (Invitrogen) or FuGene HD (Roche, Mannheim, Germany), according to the manufacturers' instructions.
ESC/iPSC-derived differentiated cells were inoculated by spin-infection. Five to ten x 10 5 of day 5 differentiated cells were suspended in 2 mL of filtered virus supernatant in the presence of 8 µg/mL polybrene (Sigma) and transferred into one well of a 24 well plate. The plate was then centrifuged at 1,800 rpm for 2 hours at 25˚C and the cells were seeded onto OP9 cells.
Establishment of mouse iPSCs
We established two new iPSC lines (clone 24 and clone 2) from E13.5 MEFs harvested from C57BL/6 mice (Nihon SLC, Hamamatsu, Japan). Introduction of the 4 factors described by the Yamanaka group was carried out as previously described. 20 Alkaline phosphatase staining was carried out using a leukocyte alkaline phosphatase kit (Sigma). 
Transplantation experiments
Results
In vitro hematopoietic induction from mouse ESCs
In this study, we have used the OP9 co-culture induction method to differentiate mouse ESCs/iPSCs into the hematopoietic lineage. 17 This co-culture method has been widely used for hematopoietic induction. When ESCs were put onto OP9 stromal layer, mesodermal cell clusters emerged around day 5 of the induction ( Figure 1A ). Essentially all of the ESC-derived cells on day 5 were Flk1 + ( Figure 1B ). These cells were harvested and sub-cultured on fresh OP9 cells. Around day 6 to 8, HPC-like cells emerged. These cells were differentiated into mature hematopoietic cells around day 10 -14 ( Figure 1A ) and subsequently underwent apoptotic cell death.
The expression of Lhx2 mRNA was next examined. The undifferentiated ESCs expressed a lower amount of endogenous Lhx2 mRNA ( Figure 1C ). The level of Lhx2 mRNA gradually increased as the cells differentiated into mesodermal cells over 5 days, and Lhx2 expression was undetected in hematopoietic cells on day 8 ( Figure 1C ).
In vitro induction of KSL cells from ESCs by enforced expression of Lhx2
Differentiating ESCs were infected with a retroviral vector carrying Lhx2 (Lhx2) and an empty vector (EGFP) on day 5, and the cells were then further cultured on OP9 in the presence of SCF and IL-6 ( Figure 1D ,E), since Lhx2-transduced, ESC-derived HPCs have been shown to preferentially grow in the presence of SCF and IL-6. 21 In control, almost all hematopoietic cells were fully differentiated and subsequently disappeared by completing terminal differentiation by 2 weeks of the differentiation induction. Consequently, only OP9 cells were present in culture on day 20
( Figure 1F ). In contrast, the Lhx2 transduction gave rise to cells that continued to proliferate.
Some cells grew underneath OP9 stromal cells, which was known as 'pseudoemperiopolesis', indicating that these cells were immature hematopoietic cells ( Figure 1F ). In control, the differentiated cells stopped increasing by day 14 ( Figure 1G ). In contrast, the Lhx2-transduced cells were continuously increased ( Figure 1G ). The Lhx2 transduction did not affect cell death ( Figure 1H ), suggesting that the continued cell growth by Lhx2 would largely result from the enhanced cell proliferation.
Next, the increasing cells were analyzed. FACS analyses revealed that almost all Lhx2- 
Establishment of C57BL/6 mouse-derived iPSCs
Since iPSCs are an important cell source for regenerative medicine, we have challenged whether the Lhx2 transduction would be effective in iPSCs. Mouse iPSC lines were newly established from
MEFs from C57BL/6 strain using the 4 factors described by Yamanaka et al, Oct3/4, Sox2, Klf4, and c-Myc. 22 We confirmed that established iPSCs were positive for representative ESC markers ( Figure S2A,B) . In addition, the iPSCs were capable of producing various lineages of 
Comparison between Lhx2 and Hoxb4
Previously, it has been reported that over-expression of Hoxb4 induced HSCs from ESCs. Figure 2C ). In contrast, the population of KSL cells was relatively constant in the case of Lhx2
( Figure 2C ).
We next evaluated whether Lhx2 would regulate Hoxb4 expression and candidate Hoxb4 target genes or not. The enforced expression of Lhx2 did not up-regulate Hoxb4 mRNA, and
Hoxb4 was also ineffective in inducing Lhx2 expression in differentiating ESCs ( Figure 2D ).
Hemgn and Laptm4b, which have been shown to be Hoxb4 target genes in primary murine Lin -bone marrow cells and hematopoietic progenitor cells line EML, respectively, 23, 24 were not upregulated by Hoxb4 in the ESC differentiation induction ( Figure 2E ). The expression of c-Mpl which has been shown to be up-regulated in embryoid bodies with inducible Hoxb4 expression 25 was also unaffected ( Figure 2E ). These data suggest that trans-activation targets of Hoxb4 were (Figure 2E ), suggesting some roles of Lhx2 on Laptm4b regulation.
We next examined whether there was synergism between Lhx2 and Hoxb4. Cells cotransduced with the Lhx2 and Hoxb4 retroviral vectors were separated using EGFP and EYFP, respectively ( Figure 2F ). In the case of cells expressing either Lhx2 or Hoxb4 alone, 99.0% and 18.2% of the ESC-derived hematopoietic cells were Lin -, respectively ( Figure 2G ). ESCs transduced with both genes exhibited an intermediate phenotype, i.e., 75.7% were Lin -( Figure 2G ).
In addition, the frequency of KSL cells was decreased in the co-transduced cells compared to the Lhx2-transduced cells ( Figure 2G) . Therefore, the KSL cell induction activities of Lhx2 and Hoxb4 are not synergistic. Figure 3F ). In the presence of Lhx2, EryP and EryD could be detected, although their frequencies were decreased ( Figure 3F ). On day 8 and day 11, the cells expressed embryonic globin (βH1) and adult globin (βmaj), respectively ( Figure 3F ), which confirmed that these erythroid cells were EryP and EryD, respectively. These data showed that EryP and EryD were produced in the presence of Lhx2.
Differentiation ability of Lhx2-transduced hematopoietic cells in vitro
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Differentiation and repopulation abilities of Lhx2-transduced hematopoietic cells in vivo
Next, LTR activity was assessed. Sixteen weeks after transplantation, approximately 30%
of the hematopoietic cells in the bone marrow and spleen were donor origin in the representative transplanted mouse ( Figure S3A ,B). They contributed to myeloid, erythroid, megakaryocyte and B-lymphoid populations, indicating the multi-lineage, long-term engraftment capacity of the ESCderived hematopoietic cells by Lhx2 transduction. On the other hand, no donor cells were detected in the thymus ( Figure S3C ). The LTR activities were observed in multiple recipient mice (Table   S2 and Figure S4A ).
It would be predicted that long in vitro culture of cells might exhaust LTR activity.
Therefore, we compared LTR activity of Lhx2-transduced cells between day 18 and 31 of the culture. Approximately 100 fold of amplification was seen between day 18 and 31 (Table S2 ).
Donor cell chimerism in the transplanted mice was analyzed and the results were similar in the both cases ( Figure S4B ), indicating that the LTR activity was sustained by Lhx2 at least until day 31 of culture.
Next, we evaluated the functional activity of transplanted hematopoietic cells. EGFP + cells
were sorted from the bone marrow of primary recipient mice 12 weeks after transplantation and subjected to colony formation assays and secondary transplantation experiments ( Figure 5A ,B).
These cells were capable of producing hematopoietic colonies ( Figure 5C ). Furthermore, EGFP + cells contained secondary LTR activity ( Figure 5D ,E) The secondary LTR activity was seen in the multiple primary recipients. These data clearly excluded a possibility that the secondary engraftment ability could be due to retroviral integrative changes of the Lhx2-transduced cells.
No signs of myeloid proliferative disorder were observed in the recipient mice in clear contrast to the results observed in mice transplanted with Lhx2-transduced adult HSCs. 27 
In vivo nature of iPSC-derived hematopoietic cells
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Comparison between ESC-derived and iPSC-derived hematopoietic cells in vivo
We next compared nature of iPSC-derived cells with that of ESC-derived cells. First, the frequency of KSL cells induced by Lhx2 transduction were compared and no differences were seen ( Figures 1I,S2F ). In the case of Hoxb4 transduction, the population of KSL cells from iPSCs was also comparable to that from ESCs ( Figure 2C ). Next, LTR activity was compared. After 
We did not detect donor-derived T-lymphoid cells in the recipient mice transplanted with
Lhx2-transduced HSC-like cells derived from iPSCs ( Figure 6F ). The similar results were observed in the case of ESCs ( Figure S3C ), indicating that the failure of T-lymphoid contribution was not caused by the nature of iPSCs. It would be expected that Lhx2 might inhibit T-lymphoid differentiation.
Lhx2 expression in vivo
Finally, we confirmed the expression of exogenous Lhx2 in vivo, since it would be postulated that integrative proviral construct itself would act as modulators of transcription factors or epigenetic Figure 7A ), but not in control mice, indicating that endogenous Lhx2 mRNA was not expressed in any hematopoietic cell fractions examined ( Figure 7B ). To know protein expression, FLAG-tagged Lhx2 (FLAG.Lhx2) was transduced into ESC-derived cells, and the transduced HSClike cells were transplanted. The donor-derived differentiated cells were purified, and analyzed by western blotting ( Figure 7C ). The FLAG.Lhx2 fusion protein was specifically detected in EGFP + differentiated hematopoietic cells, indicating that the retrovirally-transduced Lhx2 was being translated in vivo.
For
Discussion
In this study, we demonstrated that Lhx2 conferred LTR capacity to ESC/iPSC-derived hematopoietic cells, with the exception of the T-lymphoid lineage. The new system we developed, i.e., the Lhx2 transduction and sub-culture on OP9 stromal cells, may be useful for investigating the molecular mechanisms by which HSCs develop the pathways underlying lineage specification from pluripotent stem cells.
The multi-differentiation potentials of Lhx2-transduced hematopoietic cells
Our data presented here demonstrated that the Lhx2-transduced HSC-like cells were multi-potent for long term, raising a question of whether the maintenance of HSC-like cells by Lhx2 would be caused by the inhibition of hematopoietic differentiation or not. The data in the literature may provide some clues to the inhibitory actions. Lhx2 binds to Ldb1 (NLI), a LIM-domain binding protein, 28 a known member of the Gata-1/2 multi-protein complex, which is composed of Gata-1/2, Ldb1, Scl, E47, and Lmo2. 29 We have previously showed that Gata-1 knockout erythroid cells acquired multi-differentiation potentials. 30 The data raises a possibility that multi-potentials of the 
Comparison between Lhx2 and Hoxb4
Hoxb4 has been known to induce engraftable HSCs from mouse ESCs 10 and has also been used to produce iPSC-derived engraftable hematopoietic cells which were effective for treatment of a mouse model of sickle cell anemia. 31 Like Hoxb4, Lhx2 also induced HSC-like cells from ESCs/iPSCs, suggesting that Lhx2 might be also theoretically useful for regenerative medicine.
However, one study has demonstrated that HOXB4 is dispensable for inducing hematopoiesis from human ESCs. 32 Therefore, whether or not LHX2 could induce HSC-like cells from human ESCs/iPSCs remains to be an important issue.
Understanding of the molecular function of Lhx2 as well as Hoxb4 in mice might be helpful 35, 10 implying that later possibility seems likely.
Failure of T-lymphoid repopulation by Lhx2-transduced hematopoietic cells
Several papers have been reported that the Hoxb4-induced HSCs have low B/T-lymphoid repopulation activity in vivo. 34, 35 In contrast, the Lhx2-transduced HSC-like cells could be contributed into B-lymphoid cells even in the non-immunocompetent recipient mice. Therefore, the Lhx2 transduction would be useful for investigating iPSC-derived B-lymphoid cells in vivo.
On the other hand, the failure of the Lhx2-transduced HSC-like cells to differentiate into Tlymphoid cells raises the possibility that Lhx2 might disturb T cell differentiation. In Drosophila,
Apterous, a Lhx2 homolog, has been shown to inhibit the function of the Gata factor Panier. 36 Thus, one could speculate that Lhx2 might inhibit the function of Gata-3, a master regulator of T cell differentiation. 37 Interestingly, both Lhx2 and Gata-3 have been implicated in stem cell maintenance in hair follicles 16, 38 and in eye development, 14, 39, 40 suggesting a functional interaction between Lhx2 and Gata-3.
Investigation of hematopoietic cells derived from iPSCs by comparing with those from ESCs
Using the combination of OP9 differentiation induction and the Lhx2 transduction, we could investigate nature of hematopoietic cells derived from iPSCs by comparing with that from ESCs.
All assays we carried out showed that the iPSC-derived hematopoietic cells displayed essentially identical behavior to the ESC-derived cells. For personal use only. on January 16, 2018. by guest www.bloodjournal.org From
